Old Web
English
Sign In
Acemap
>
authorDetail
>
Brett Duersch
Brett Duersch
Merck & Co.
Pharmacology
Aprepitant
Medicine
Corticosteroid
Antagonist
4
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Small molecule parenteral drugs: Practical aspects of stress testing
2016
Andreas Abend
Brett Duersch
Kyle Fiszlar
Show All
Source
Cite
Save
Citations (1)
Leveraging Solid State Form and Physiochemical Properties for Early Clinical Formulation Efforts: Opportunities and Challenges During Telcagepant Liquid Capsule Development
2015
Dan Zhang
Allen C. Templeton
William Anthony Marinaro
Alfred C.F. Rumondor
Filippos Kesisoglou
Brett Duersch
Karen C. Thompson
Joyce Stellabott
Michael H. Kress
Show All
Source
Cite
Save
Citations (1)
Reply to: assessing physico-chemical compatibility of concomitantly diluted antiemetics including palonosetron-HCl and fosaprepitant dimeglumine
2014
Cancer Chemotherapy and Pharmacology
Brett Duersch
Show All
Source
Cite
Save
Citations (2)
Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids
2013
Cancer Chemotherapy and Pharmacology
Susan Sun
Joseph Schaller
Jiri Placek
Brett Duersch
Show All
Source
Cite
Save
Citations (10)
1